Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT07226999 · RECRUITING

Trial details

NCT number: NCT07226999
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Small Cell Lung Cancer (SCLC)

Start date: 2025-12-09
Primary completion: 2030-06-14
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.